Peritoneal Malignant Mesothelioma clinical trials
6 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
- Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
- Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Peritoneal Malignant Mesothelioma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.